KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Petmed Express (PETS) EBITDA Margin (2016 - 2025)

Petmed Express has reported EBITDA Margin over the past 16 years, most recently at 25.75% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 2488.0% year-over-year to 25.75%; the TTM value through Dec 2025 reached 31.56%, down 3180.0%, while the annual FY2025 figure was 1.57%, 269.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 25.75% at Petmed Express, down from 18.89% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 13.09% in Q3 2021 and troughed at 66.69% in Q2 2025.
  • A 5-year average of 2.59% and a median of 1.09% in 2023 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: surged 722bps in 2024 and later tumbled -7331bps in 2025.
  • Year by year, EBITDA Margin stood at 9.67% in 2021, then crashed by -97bps to 0.3% in 2022, then plummeted by -782bps to 2.05% in 2023, then surged by 58bps to 0.87% in 2024, then plummeted by -2873bps to 25.75% in 2025.
  • Business Quant data shows EBITDA Margin for PETS at 25.75% in Q4 2025, 18.89% in Q3 2025, and 66.69% in Q2 2025.